P16 has been proved as an activating factor of tumor suppressor pathways and inactivated in many different human tumor types.33 To understand the above phenomenon in detail, we first performed QPCR and found that expressions of P15 and P16 were upregulated in primary Cbx4−/−, KrasG12D cells. Here, CBX4 is linked to neoplasm.